Mesothelioma Research Limitations and Computed Tomography

Mesothelioma Research Limitations and Computed Tomography

Free Online Articles Directory

Why Submit Articles?
Top Authors
Top Articles
FAQ
ABAnswers

Publish Article

0 && $ .browser.msie ) {
var ie_version = parseInt($ .browser.version);
if(ie_version Login

Email

Password

Remember me?
Lost Password?

Home Page > Health > Cancer > Mesothelioma Research Limitations and Computed Tomography

Categories
AdvertisingArts & EntertainmentAutomotiveBeautyBusinessCareersComputersEducationFinanceFood and BeverageHealthHobbiesHome and FamilyHome ImprovementInternetLawMarketingNews and SocietyRelationshipsSelf ImprovementShoppingSpiritualitySports and FitnessTechnologyTravelWriting

]]>

Mesothelioma Research Limitations and Computed Tomography

By: Montwrobleski77
Posted: Oct 07, 2010

Another interesting study is called, “Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant Mesothelioma” by Hans-Beat Ris, Hans Jörg Altermatt, Bernhard Nachbur, J. Charles M. Stewart, Qiang Wang, Chang Kee Lim, Raymond Bonnett, Ulrich Althaus – International Journal of Cancer Volume 53, Issue 1, pages 141–146, 2 January 1993. Here is an excerpt: “Abstract – The influence of the time interval (TI) between drug administration and laser activation on selectivity of meta-tetrahydroxy- phenylchlorin(mTHPC)-mediated photodynamic therapy (PDT) for tumour tissue was assessed in BALB/c nude mice bearing human malignant mesothelioma xenografts. Following i.p. administration of 0.3 mg/kg mTHPC, a light dose of 10 J/cm2 and 0.1 W/cm2 was delivered at 650 nm on the tumour and an equal-sized area of the hind leg after 4. I2, 24 and 36 hr and 2,3, 4,5 and 6 days to groups of 6 animals (surface irradiance). Then, 72 hr after light delivery, the depth of necrosis was measured in the tumour and in the skin and underlying muscle of the hind leg. Photosensitized necrosis occurred in normal tissue at TI from 4 hr to 3 days and in the tumour at TI from I2 hr to 4 days. The therapeutic ratio of mTHPC-PDT varied significantly with the time interval between drug administration and laser activation and was greatest at an interval of 3 days. mTHPC concentration was measured in 3 control unirradiated animals at all time points in normal tissues and in tumour tissue, and found to be the same in both tissues. Thus the tissue concentration of mTHPC was of limited use as regards the prediction of photosen-sitizing effects in the tumour model.”

One interesting study is called, “The Journal of Thoracic and Cardiovascular Surgery” - Vol 96, 171-177, – 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association. Here is an excerpt: “The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural Mesothelioma” by VW Rusch, JD Godwin and WP Shuman – Department of Surgery, University of Washington, Seattle 98195. Here is an excerpt: “Between October 1983 and April 1987, 20 patients with malignant mesothelioma underwent computed tomography scans of the chest and upper abdomen to evaluate the extent of disease before treatment. Twelve of these 20 patients deemed to have some potential for long-term survival had scans performed every 3 months after operation to help detect recurrent disease. Anatomic correlation of computed tomography scan findings was available in all 20 patients. The limitations of computed tomography in initial evaluation were its difficulties in assessing (1) chest wall involvement (nine patients), (2) mediastinal lymph nodes (four patients), (3) transdiaphragmatic extension of tumor (four patients), and (4) peritoneal studding and solid organ metastases less than 2 mm in size (one patient). Computed tomography was helpful in detecting recurrent disease in the 12 patients having long-term follow- up. In six of eight cases with histologically proved recurrence, computed tomography detected tumors from 1 to 8 months before the onset of signs or symptoms. Although computed tomography is known to provide far more information about the extent of disease than plain radiographs, it remains an imperfect tool for the staging of disease in patients with malignant mesothelioma. Despite its limitations, computed tomography is probably the most accurate way to provide follow-up for patients during treatment.” Eur J Respir Dis. 1984 Apr;65(3):162-8.

Another interesting study is called, “Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment.” By Law MR, Hodson ME, Turner-Warwick M. Here is an excerpt: “Abstract – A series of 140 patients with malignant pleural mesothelioma is reported. Clinical presentation was delayed in cases without a large effusion, but there was extensive tumour at presentation, shown by thoracoscopy, thoracotomy or computed tomography, in all patients investigated. Thoracoscopy was a useful diagnostic alternative to thoracotomy. With progression of disease, mesothelial extension was more important than distant metastases, which were usually too small and sparse to produce symptoms. Skin deposits of tumour in sites of previous invasive procedures did not cause pain or other clinical problems, and we consider that diagnostic and therapeutic procedures should not be withheld to avoid them. In the management of recurrent pleural effusions, intrapleural bleomycin, preceded by aspiration and followed by suction, was a useful alternative to surgery. Pneumothorax, spontaneous or iatrogenic, required decortication. Adequate pain relief was difficult; radiotherapy and nerve blocking procedures were not effective and opiates were often necessary.”

We all owe a debt of gratitude to these fine researchers. If you found any of these excerpts interesting, please read the studies in their entirety.

Montwrobleski77 – About the Author:

Monty Wrobleski is the author of this article. For more information please click on the following links

Depuy Hip Recall Attorney

Malignant Mesothelioma

Source: http://www.articlesbase.com/cancer-articles/mesothelioma-research-limitations-and-computed-tomography-3423275.html

]]>

Increase your traffic today just by submitting articles with us, click here to get started.

Liked this article? Click here to publish it on your website or blog, it’s free and easy!

Rate this Article

1
2
3
4
5

vote(s)
1 vote(s)

Feedback
Print

Article Tags:
asbestos exposure, mesothelioma cancer, asbestos attorney, lawyer, class action lawyers, law suit, suite, law firm, law firms, litigation, treatment, lung cancer, patients, victims, meso lawyer, faq, navy veterans, symptoms, asbestos poisoning, damage, pl

Latest Cancer Articles
More from Montwrobleski77

Breast Cancer, Regain your Health by Healing it Naturally

The way we treat breast cancer now days by just removing growths has not reduced the number of people dying of the disease. The modern medical approach with their harsh treatments has not solved the cancer problem. A genuine cure can only be achieved when someone removes the underlying causes of the problem which is the reason why it first grew. Healing breast cancer means learning about it by gaining a little knowledge.

By: Alan Wighton

Health >
Cancer
May 26, 2011

Generic arimidex (Anastrozole) is the effective cancer medication to treat breast cancer

Breast cancer is the most common malignancy in women and the second leading cause of cancer death, exceeded only by lung cancer in 1985

By: Iam Punkaj

Health >
Cancer
May 26, 2011

What You Should Know About Colon Cancer Symptoms

Knowing colon cancer symptoms is important. These signs are not always noticeable, however anyone can learn how they feel and what they look like. First of all, you have to be more familiar with some things regarding the colon since that will help you to know what colon cancer symptoms might feel like.

By: Sandy Rutherforde

Health >
Cancer
May 25, 2011

Everything about Mesothelioma

Mesothelioma is a rare form of cancer that develops in the mesothelium layer of body lining the internal body organs.

By: Rod DeLlano

Health >
Cancer
May 25, 2011

Bladder growth and How to Treat It

The bladder is a hollow muscular organ located in the pelvis inside the body and is reliable pro holding urine. Bladder growth is a cruel growth surrounded by the urinary bladder. Growth of the bladder results in the growth of abnormal cells in the bladder, which multiply further than control.

By: gullfraz

Health >
Cancer
May 24, 2011

Gene Targeting Technology and Craniofacial Development

Collectively Cleft Lip and Cleft Palate has a major clinical impact requiring surgical, dental, orthodontic, speech, hearing and psychological treatments or therapies throughout childhood

By: Montwrobleski77